instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: Sweeping testing for the coronavirus among the entire crew of the Roosevelt has already yielded a curious result: The majority of the positive cases so far are among sailors who are asymptomatic. With so many of the crew symptom-free, it is unclear how many of them had been infected and recovered without anyone realizing they had contracted the virus. Many of these infections could have finished their cycle before testing of the crew began. The extent of the infections aboard the vessel should become more clear with results of the new “outbreak investigation” the Navy announced that will use serology testing developed by the U.S. Centers for Disease Control and Prevention (CDC). The serology tests look for the presence of specific antibodies that are created by the immune system’s attack response to the presence of the virus and remain in the blood for a period of time. “We are seeking crew member volunteers,” Navy Surgeon General Rear Admiral Bruce Gillingham told reporters. The roughly thousand volunteers who are being sought for testing over the next week or so will also be swabbed again for COVID-19, the respiratory disease caused by the virus, as well as asked to answer a short survey, officials said. The U.S. coronavirus death toll - the highest in the world - surged past 35,000 on Friday. It also claimed the life of a sailor from the Theodore Roosevelt this week. The Navy’s testing of the entire 4,800-member crew of the aircraft carrier - which is about 94% complete - was an extraordinary move in a case that already has led to the firing of the ship’s captain and the resignation of the Navy’s top civilian official. It has also given scientific researchers a case study about how the virus spreads asymptomatically in a confined environment among mostly younger adults. That cohort has been somewhat underrepresented in the epidemiological data so far. As of Friday, some 660 sailors - nearly 14% of the crew - had tested positive for the coronavirus. The Navy has said that about 60% of those positive tests were among sailors who were symptom-free. The Navy said medical staff on the island of Guam, where the ship pulled into port, would take the samples and collect questionnaire results. The actual serology tests will be sent to the CDC in Atlanta for analysis. The data could further shed light on how the coronavirus spreads undetected, which could help inform the U.S. national response to the pandemic and efforts to restart the economy. “We will also be sharing that with the White House task force so that that information can be used for the benefit of the nation,” Gillingham said. Claim: U.S. to start antibody testing of sailors on coronavirus-hit aircraft carrier.
answer:
The U.S. Navy said on Friday it will conduct antibody testing of sailors aboard the coronavirus-hit aircraft carrier Theodore Roosevelt to determine whether they were exposed to the virus as it spread through the ship.


question:
Paragraph: "Cost data for flibanserin is not provided. Some projection of cost should be available for any drug this far along in Phase III trials – and for which the company has already begun marketing campaigns. If not from the company, then from stock analysts. The story properly quantifies the reported benefits in absolute terms which allows the reader to see that they are small. (Results are described in Quality of Evidence comments.) In an interview a study researcher conceded that the absolute number of women reporting benefit was not large. The story provided statistics on common side effects including daytime sleepiness, dizziness, fatigue, anxiety, dry mouth, nausea and insomnia. These side effects resulted in 15% of those taking flibanserin vs 7% taking placebo withdrawing from the study. The story does a good job of presenting and evaluating the available evidence. Results are presented in absolute terms, for example that just under one third of women taking flibanserin reported improvement in sexual distress/desire compared to approximately one fifth of women taking placebo. In contrast, these results were presented in relative terms by the manufacturer. Except for the headline, "" ‘Female Viagra’ May Treat Low Sexual Desire"", this story avoids disease mongering and notes that ""hypoactive sexual desire disorder"" in women is a controversial diagnosis. The text clarifies that while the popular press is dubbing flibanserin as the ""female Viagra"", it is not similar to Viagra or other drugs to treat erectile dysfunction. Conflicts of interest are disclosed. The story noted that the study researcher interviewed is a paid consultant for the drug manufacturer. An alternative point of view is provided by two independent experts, a psychologist and a sex-therapist. The independent sources comment on the role that personal relationships play in sexual desire and experience which was not addressed or acknowledged by the researchers. The story indicates that an alternative drug called the Intrinsa testosterone patch is available in Europe, but not in the U.S. The story also notes a difference between these dugs; Intrinsa is a hormonal treatment compared to flibanserin which is a non-hormonal. The story indirectly informs that reader that flibanserin is not available by noting that it is in phase III clinical trials and that the manufacturer is seeking FDA approval (despite early direct to consumer marketing campaigns). The story makes it fairly clear that this is a new treatment – also for a new and controversial diagnosis. The story was apparently based on research presented in abstract form at the annual clinical meeting of the American College of Gynecologists and Obstetricians, although this information has not been published in independently, peer-referred scientific journals. There is no direct evidence that it relied largely on a news release. In fact, the use of interviews with independent experts makes it clear that independent reporting took place." Claim: ‘Female Viagra’ May Treat Low Sexual Desire
answer:
"This story reports on a investigational drug, flibanserin, that is being developed to treat what is a controversial diagnosis called ""hypoactive sexual desire"" in women. The popular press has dubbed this drug ""Female Viagra"" despite that fact that it has few similarities to drugs that treat erectile dysfunction. Preliminary research examining the drug’s efficacy in treating sexual distress and/or low sexual desire were presented at the May 2010 annual clinical meeting of the American College of Obstetricians and Gynecologists (ACOG). To place the story in context, previous reports from the manufacturer claimed that flibanserin resulted in ""clinically significant"" improvement in the number of sexually satisfying events reported by women taking the drug vs. those taking placebo, an absolute difference of 0.7 events per month. The story was detailed and did a good job of presenting information in absolute terms so that the reader could clearly see that reported benefits were small and of unknown clinical significance. Good reminders that this is a controversial diagnosis and that ""some experts see it as the medicalization of what is for many women a relationship issue."""


question:
Paragraph: Thirteen search warrants involving marijuana cultivation were served Monday by Riverside County sheriff’s deputies and state Department of Fish and Wildlife personnel in the unincorporated Aguanga area. In addition to the eradicated plants, 2,356 pounds of processed marijuana and 14 firearms were seized, the Sheriff″s Department said. One of the grows was using an extremely toxic pesticide that is banned in the United States, the department noted. “Marijuana cultivation negatively impacts the environment in many ways including diminishing and poisoning the water table and pesticides adversely affecting the health of neighboring residents,” the department said. Aguanga is about 55 miles (88.5 kilometers) north of San Diego. Claim: Search warrants target illegal Southern California pot grows.
answer:

More than 15,000 marijuana plants were eradicated and six people were arrested during raids on illegal grows in Southern California, authorities said Tuesday.